Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125815882 | 12581588 | 2 | F | 201607 | 20160715 | 20160722 | 20160722 | PER | PHEH2016US018009 | SANDOZ | 45.11 | YR | M | Y | 0.00000 | 20160722 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125815882 | 12581588 | 1 | SS | VOTRIENT | PAZOPANIB HYDROCHLORIDE | 1 | Oral | 800 MG, QD | 0 | 800 | MG | QD | |||||||
125815882 | 12581588 | 2 | PS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | 77575 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125815882 | 12581588 | 1 | Renal cancer |
125815882 | 12581588 | 2 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125815882 | 12581588 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125815882 | 12581588 | 1 | 20150427 | 0 |